NOI - A Non-Invasive Prognostic Biomarker - Circul
National Institutes of Health · NATIONAL INSTITUTES OF HEALTH OLAO
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 75N98027Q00007 in this department, oldest first.
- Oct 13, 2026 · this noticeCombined Synopsis/Solicitation
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Decide bid or no bid before the response deadline.
- Look at the past winners for likely competitors and teaming partners.
- Follow the opportunity to hear about amendments and the award.
What the notice says
(i)This is a combined synopsis/solicitation for commercial items prepared in accordancewith the format in FAR Subpart 12.6, as supplemented with additional information includedin this notice. This announcement constitutes the only solicitation; proposals are beingrequested, and a separate written solicitation will not be issued. (ii)The solicitation number is 75N98027Q00007. This solicitation is issued as a Notice ofIntent (NOI) for a non-competitive combined synopsis/solicitation to award a contract orpurchase order without providing for full and open competition (including brand-name, ifappl… (show all)
icable). This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii). The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to University of Alabama at Birmingham, 701 S 20th Street, Birmingham, AL 35294-0001-0001, for research support to develop and validate circulating cell-free DNA (cfDNA) as a blood-based biomarker of chlorine-induced acute lung injury, using the Matalon Laboratory's sole-source validated murine chlorine inhalation injury model, established mechanistic expertise, access to its actively enrolling aspiration pneumonitis biorepository (human proxy cohort), existing collaborative infrastructure with the NHLBI Laboratory of Precision Omics, and continuity with peer-reviewed federal funding (NIH R01 HL031197). These capabilities are not available from any other source and are essential to the project's feasibility. (iii)The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026. (iv)The associated NAICS code is 541380, Testing Laboratories and Services, and the small business size standard is $19.0 million. This requirement is not set aside for small business.
Who won similar work
10 award notices on SAM.gov in the last 24 months. Match: Same agency (National Institutes of Health), same NAICS 541380.
| Winner | Awards | Value | Last |
|---|---|---|---|
| AZENTA US INC | 1 | $35.0M | Dec 2, 2024 |
| NORGEN BIOTEK CORP | 1 | $157K | Sep 19, 2025 |
| CDI LABORATORIES INC | 1 | $50K | Mar 17, 2025 |
| HISTOSERV, INC | 1 | $29K | May 5, 2025 |
| NEW YORK GENOME CENTER, INC. | 1 | – + 1 shared | Jan 10, 2025 |
| SEQMATIC, LLC | 1 | – + 1 shared | Jan 8, 2025 |
| UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL ADMINISTRATIVE OFFICE BUILDING, SUITE 2200 104 AIRPORT DRIVE, SUITE 2200, CB 1350 Chapel Hill NC 27599 USA | 1 | – + 1 shared | Jan 10, 2025 |
| UNIVERSITY OF SOUTHERN CALIFORNIA 3720 S FLOWER STREET FL 3 Los Angeles CA 90089 USA | 1 | – + 1 shared | Jan 10, 2025 |
| Washington University, The CAMPUS BOX 1054 ONE BROOKINGS DRIVE SAINT LOUIS MO 63130 USA | 1 | – + 1 shared | Jan 8, 2025 |
| INFINITY BIOLOGIX LLC | 1 | – + 1 shared | Jan 8, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.
- Sep 19, 2025NORGEN BIOTEK CORP$157KQ--Small RNA characterization of urinary exosomes
- May 5, 2025HISTOSERV, INC$29KSignatures of aging outcomes
- Mar 17, 2025CDI LABORATORIES INC$50KCDI Laboratories HuProt v4.0 Human Proteome Microarrays with Biospecimen Screening Service and Analysis
- Jan 10, 2025NEW YORK GENOME CENTER, INC.$150.0M (shared ceiling)B--NCI IDIQ Contract Genomic Characterization Center
- Jan 10, 2025UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL ADMINISTRATIVE OFFICE BUILDING, SUITE 2200 104 AIRPORT DRIVE, SUITE 2200, CB 1350 Chapel Hill NC 27599 USA$150.0M (shared ceiling)B--NCI IDIQ Contract Genomic Characterization Center
- Jan 10, 2025UNIVERSITY OF SOUTHERN CALIFORNIA 3720 S FLOWER STREET FL 3 Los Angeles CA 90089 USA$150.0M (shared ceiling)B--NCI IDIQ Contract Genomic Characterization Center
- Jan 8, 2025INFINITY BIOLOGIX LLC$150.0M (shared ceiling)B--NCI IDIQ Contract Genomic Characterization Center
- Jan 8, 2025Washington University, The CAMPUS BOX 1054 ONE BROOKINGS DRIVE SAINT LOUIS MO 63130 USA$150.0M (shared ceiling)B--NCI IDIQ Contract Genomic Characterization Center
- Jan 8, 2025SEQMATIC, LLC$150.0M (shared ceiling)B--NCI IDIQ Contract Genomic Characterization Center
- Dec 2, 2024AZENTA US INC$35.0MQ--Childhood Cancer Data Initiative (CCDI)
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 0 of these past winners lobbied Natl Institutes of Health (NIH) since 2024 (0 filings)
- 0 of their lobbyists list a past Natl Institutes of Health (NIH) job
- No corporate PAC money from them to the overseeing committees since 2024
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 0 bills named on the past winners' lobbying filings
- 0 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.
- 0 of the past winners are listed companies
- 0 insider buys and 0 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.